Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer.

Iran J Pathol · 2023 · PMC10646737 · PMID 38024548

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

of borderline significanceP =0.06so close (0.05 < p ≤ 0.1)

Contrarily, the invasive lobular carcinoma (ILC) showed a reverse association of borderline significance level (OR=0.25, 95% CI: 0.06-1.08, P =0.06) with HER2 positive status, only in univariate analysis.

also in 389 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.